How will new products help Moderna’s stock price?  MRNA COVID RSV MRV FLU Vaccines Moderna stock
Channel: DanMarket Investor Channel (DanMarketL)
Date: 2023-05-15

Moderna’s net income is almost completely from their COVID vaccines.  With COVID fading, their revenues and profits have been dropping.  Fortunately, they have new products in the development pipeline.  In this video, I will talk about Moderna’s COVID vaccine revenues and potential revenues from their RSV vaccine, flu vaccine and CMV vaccine.  I will talk about my own price target for Moderna for the next few months. 

Subscribe to my Twitter account to see my latest stock trades and to get my  latest news updates:
   twitter.com/DanMarketL   

=======
Disclaimer:

The content in any of the DanMarket L(TM) Youtube videos shall not be construed as financial advice and may be outdated or inaccurate; it is your responsibility to verify all information.  The Youtube videos in this channel are for entertainment purposes only.  If stocks or companies are mentioned, Dan MAY have an ownership interest in them -- DO NOT make buying or selling decisions based on videos in this Youtube channel. If you need advice, please contact a qualified CPA, attorney, financial advisor, or the appropriate professional for the subject you would like help with. Linked items may create a financial benefit for DanMarket L(TM).  Any use of other media is by fair-use or license only. 
To contact Dan, please email danmarket47@gmail.com.k stock symbol SVB has been shut down by the bank regular of the state of California.  Silicon Valley Bank was founded in 1983.  It ranked as the 16th largest bank in the U.S.